Epicrispr Biotechnologies Partners with Springbok Analytics to Integrate AI Muscle Analysis in First-in-Human FSHD Study Originally posted to BusinessWire on April 23, 2025 – Advanced MRI analytics to enhance early… Read More »
Press Release: Epicrispr Biotechnologies Partners with Springbok Analytics to Integrate AI Muscle Analysis in First-in-Human FSHD Study
A tribute to Judy Seslowe
A transformative force for the FSHD Society by June Kinoshita, FSHD Society Judy Seslowe, whose life was marked by compassion, leadership, and unwavering commitment, passed away on April 13,… Read More »
Hope in the laboratory
Taking back control of my destiny through research BY HELOISE HOFFMANN, STANFORD UNIVERSITY For the past year, I have been working alongside a team of fellow undergraduates at Stanford University… Read More »
Epicrispr Biotechnologies achieves milestones in developing groundbreaking therapy for FSHD
Epicrispr Biotechnologies, a South San Francisco-based biotech company, has announced two major advancements in its mission to develop transformative therapies for genetic diseases. The company secured $68 million in Series… Read More »
Avidity Biosciences Completes Enrollment in Biomarker Cohort in Phase 1/2 FORTITUDE™ Trial
Letter from Avidity Biosciences to the FSHD community: March 31st, 2025 Dear FSHD Community, Today, we are very pleased to share with you that we have completed enrollment in the… Read More »